Log In
Print this Print this

Recombinant human acid ceramidase (rhAC)

  Manage Alerts
Collapse Summary General Information
Company Plexcera Therapeutics LLC
DescriptionRecombinant human acid ceramidase (rhAC)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationLipodystrophy
Indication DetailsTreat Farber disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today